Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 8 min read

This article was created with AI assistance.

Ketamine Analgesia Drip 2026 — The Opioid-Sparing Infusion

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Pharmacology Hub — browse every related guide in one place.

Most nurses meet ketamine as an induction agent for a crashing airway. But at a fraction of that dose, run as a continuous infusion, it becomes one of the most useful analgesics in the ICU — controlling pain that opioids alone can't touch, and letting the team cut the opioid load in a patient who's becoming tolerant or over-sedated.

The short version: A sub-dissociative ("analgesic-dose") ketamine infusion blocks NMDA receptors to relieve pain and reduce opioid tolerance and hyperalgesia — at doses far below those that sedate or dissociate. It's opioid-sparing, preserves respiratory drive and blood pressure, and is used for burns, trauma, rib fractures, sickle-cell crises, and refractory pain. Watch for emergence reactions, hypertension/tachycardia, hypersalivation, and (rarely) emergence agitation; it's a controlled substance requiring the usual documentation.

Why ketamine works where opioids stall

Opioids act on opioid receptors; ketamine works mostly by blocking the NMDA receptor, a completely different pain pathway. That matters for two reasons. First, NMDA activation is central to central sensitization and opioid-induced hyperalgesia — the phenomenon where a patient on escalating opioids paradoxically hurts more. By interrupting that pathway, ketamine can break the cycle and let opioid requirements fall. Second, because ketamine doesn't rely on opioid receptors, it provides analgesia without adding to respiratory depression, which is the ceiling that limits opioid dosing in a spontaneously breathing patient. This is the whole appeal of the analgesic-dose infusion: real pain control that spares the airway and the gut.

Analgesic dose vs sedation dose — a different drug at a different rate

Dose defines the effect. The same molecule that induces anesthesia at induction doses produces only analgesia at a small fraction of that rate. A sub-dissociative infusion is titrated to pain relief, not to unconsciousness — the patient stays awake and interactive. Pushing the rate toward sedation/dissociation doses changes the risk profile entirely (dissociation, emergence phenomena, deeper monitoring needs). Always confirm which order set you're running: an "analgesia" ketamine drip and a "sedation" ketamine drip are the same drug at very different rates, and mixing them up is a real error.

Exact rates are set by your facility protocol and weight-based, but the principle is constant: start low, titrate to the pain score, and coordinate with the primary opioid so the two are adjusted together rather than stacked blindly.

Where the analgesic infusion earns its place

The opioid-sparing infusion shines in burns (severe, repeated dressing-change pain and high opioid tolerance), multi-trauma and rib fractures (where preserving respiratory drive protects the patient from splinting and pneumonia), sickle-cell vaso-occlusive crisis and other opioid-tolerant chronic-pain patients, and any ICU patient whose pain is uncontrolled despite escalating opioids or who is being pushed toward over-sedation to chase that pain. It's also used as an adjunct in procedural and post-operative settings.

What to monitor

Even at analgesic doses, ketamine has a recognizable side-effect signature. Its sympathomimetic effect tends to raise heart rate and blood pressure — usually helpful in a hypotensive trauma patient, but a caution in uncontrolled hypertension, active cardiac ischemia, or aortic pathology. It increases secretions, so watch for hypersalivation, especially with airway concerns. The best-known effect is emergence phenomena — vivid dreams, dissociation, or unpleasant hallucinations — which are far less common at analgesic doses but still occur; a calm environment helps, and benzodiazepines can treat significant reactions. Historically ketamine was avoided in head injury for fear of raised intracranial pressure, but current evidence has largely walked that back in the setting of controlled ventilation. Follow neuro and hemodynamic status, pain scores, and sedation level, and reassess the opioid dose as the ketamine takes hold.

Bedside summary

PointWhat the nurse does
Know the dose classConfirm it's the analgesic (sub-dissociative) drip, not the sedation drip
Expect opioid-sparingTitrate to pain score and lower the opioid as ketamine works
Watch hemodynamicsAnticipate higher HR/BP — caution with ischemia and severe HTN
Manage secretionsWatch for hypersalivation, especially with airway risk
Handle emergenceCalm environment; treat significant reactions with a benzodiazepine
Document controlled drugWaste and charting per policy — ketamine is a controlled substance
Bedside monitoring, in short: Verify you're running the analgesic-dose infusion, titrate it to the pain score, and drop the opioid as the ketamine takes effect. Track heart rate and blood pressure, watch for secretions and emergence phenomena, and follow your facility protocol for controlled-substance documentation.

Related: Etomidate vs ketamine for RSI · Ketamine for alcohol withdrawal · Precedex withdrawal · ICU sepsis protocol

Educational content for licensed clinicians. Always follow your facility's pharmacy dosing protocol and provider orders. Not medical advice.

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.